Medication regimen, given after L-NAME administration, included a total dose of 10 g/kg or 10 ng/kg of BPC 157 via retrobulbar application in each eye, 1 g/0.1 ml of saline/each eye or 1 ng/0.1 ml saline/each eye, or saline only via retrobulbar application in each eye (0.1 ml/each eye)
For example, a 2011 study in rats found that the peptide successfully healed various lesions and promoted healthy weight gain in models of short-bowel syndrome.14 Additionally, as researchers note in the aforementioned 2016 review on BPC-157 and the gut-brain axis, BPC 157 was successful in the therapy of GI tract, periodontitis, liver and pancreas lesions, and in the healing of various tissues and wounds. Its also written in the review that the peptide acts as a mediator of Roberts cytoprotection, defined as the counteraction of the lesions arising from direct detrimental contact with a noxious agent.7 15 Insider Tip: Though there has been some small-scale positive human research on BPC-157, most of the peptides potential uses are based on the outcomes of animal or cell studies
All references to BPC-157 relate solely to research use only , and no information should be interpreted as guidance for human consumption, animal administration, or medical use
We exclusively use pharmaceutical-grade peptides with comprehensive testingquality you can trust at prices that remain affordable
